Creative Planning’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
24,263
+4,010
| +20% | +$204K | ﹤0.01% | 2274 |
|
|
2025
Q4 | $1.01M | Sell |
20,253
-547
| -3% | -$26.6K | ﹤0.01% | 2274 |
|
|
2025
Q3 | $994K | Buy |
20,800
+13,127
| +171% | +$529K | ﹤0.01% | 2117 |
|
|
2025
Q2 | $242K | Buy |
+7,673
| New | +$246K | ﹤0.01% | 3079 |
|
|
2025
Q1 | – | Sell |
-7,202
| Closed | -$260K | – | 3707 |
|
|
2024
Q4 | $260K | Buy |
+7,202
| New | +$254K | ﹤0.01% | 2784 |
|
|
2024
Q2 | – | Sell |
-6,672
| Closed | -$228K | – | 3166 |
|
|
2024
Q1 | $228K | Buy |
+6,672
| New | +$199K | ﹤0.01% | 2480 |
|
|
2023
Q4 | – | Sell |
-128
| Closed | -$3.53K | – | 3073 |
|
|
2023
Q3 | $3.53K | Buy |
+128
| New | +$3.9K | ﹤0.01% | 2761 |
|
|
2019
Q3 | – | Sell |
-17,228
| Closed | -$570K | – | 2100 |
|
|
2019
Q2 | $570K | Buy |
17,228
+3,802
| +28% | +$130K | ﹤0.01% | 1010 |
|
|
2019
Q1 | $470K | Buy |
13,426
+4,602
| +52% | +$171K | ﹤0.01% | 1065 |
|
|
2018
Q4 | $293K | Sell |
8,824
-11,864
| -57% | -$510K | ﹤0.01% | 1245 |
|
|
2018
Q3 | $1.04M | Sell |
20,688
-31
| -0.1% | -$1.53K | ﹤0.01% | 748 |
|
|
2018
Q2 | $1.24M | Buy |
20,719
+4,415
| +27% | +$229K | ﹤0.01% | 634 |
|
|
2018
Q1 | $747K | Sell |
16,304
-5,774
| -26% | -$241K | ﹤0.01% | 882 |
|
|
2017
Q4 | $880K | Sell |
22,078
-2,956
| -12% | -$117K | ﹤0.01% | 805 |
|
|
2017
Q3 | $1M | Buy |
25,034
+6,780
| +37% | +$293K | ﹤0.01% | 719 |
|
|
2017
Q2 | $787K | Buy |
18,254
+7,349
| +67% | +$262K | ﹤0.01% | 803 |
|
|
2017
Q1 | $341K | Buy |
10,905
+7,805
| +252% | +$209K | ﹤0.01% | 1192 |
|
|
2016
Q4 | $78K | Sell |
3,100
-210
| -6% | -$4.69K | ﹤0.01% | 2036 |
|
|
2016
Q3 | $82K | Buy |
3,310
+210
| +7% | +$4.75K | ﹤0.01% | 1976 |
|
|
2016
Q2 | $63K | Hold |
3,100
| – | – | ﹤0.01% | 1977 |
|
|
2016
Q1 | $47K | Sell |
3,100
-51
| -2% | -$665 | ﹤0.01% | 2148 |
|
|
2015
Q4 | $42K | Hold |
3,151
| – | – | ﹤0.01% | 2262 |
|
|
2015
Q3 | $44K | Buy |
+3,151
| New | +$58.6K | ﹤0.01% | 2133 |
|
|
2015
Q2 | – | Sell |
-3,000
| Closed | -$36K | – | 2785 |
|
|
2015
Q1 | $36K | Hold |
3,000
| – | – | ﹤0.01% | 2254 |
|
|
2014
Q4 | $25K | Hold |
3,000
| – | – | ﹤0.01% | 2503 |
|
|
2014
Q3 | $26K | Hold |
3,000
| – | – | ﹤0.01% | 2375 |
|
|
2014
Q2 | $33K | Hold |
3,000
| – | – | ﹤0.01% | 2162 |
|
|
2014
Q1 | $27K | Hold |
3,000
| – | – | ﹤0.01% | 2201 |
|
|
2013
Q4 | $23K | Hold |
3,000
| – | – | ﹤0.01% | 2108 |
|
|
2013
Q3 | $22K | Buy |
+3,000
| New | +$20.1K | ﹤0.01% | 2040 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Creative Planning's SUPN Position: Q1 2026 in Review
Creative Planning increased its Supernus Pharmaceuticals (SUPN) stake by 20% in Q1 2026, buying an estimated $204K and bringing the position to 24,263 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2274.
Creative Planning first reported a position in SUPN in Q3 2013 and has held it in 30 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Creative Planning held 24,263 shares of Supernus Pharmaceuticals worth $1.25M as of Q1 2026.
- Creative Planning bought 4,010 Supernus Pharmaceuticals shares in Q1 2026, an estimated $204K.
- Supernus Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2274 holding.
- Creative Planning first reported a position in Supernus Pharmaceuticals in Q3 2013 and has held it in 30 quarters since.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.